The National Center to Accelerate Cures (NCAC) today, October 1, 2026 announced its official launch as a national initiative dedicated to advancing ...
Merck, known as MSD outside the U.S. and Canada, launched Your Hive of Whole Health on September 18, 2026 — a multi-year ...
Rachel Chiaverelli, PhD, has joined GSK as Executive Director, Oncology Early Translational Biomarkers, after nearly four ...
OS Therapies Aligns With FDA on Phase 3 Design, Accepts MHRA’s Project Orbis Invitation for OST-HER2
OS Therapies, Inc., a Rockville, Maryland- and New York-based clinical-stage oncology company, announced on September 17, ...
CTEM is designed to move biomedical research from the lab bench toward clinical application by putting Clark School of Engineering researchers and University of Maryland School of Medicine (UMSOM) ...
Annovis Bio, Inc., a Malvern, Pennsylvania-based Phase 3 clinical-stage biotech, announced on September 23, 2026 a collaboration with Weave Bio, an ...
SK pharmteco announced on September 22, 2026 an expanded manufacturing collaboration with Philadelphia-based Gemma Biotherapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results